Clinical Trial Result Information
Title of Study:
Multicenter, prospective, randomized, open-label trial comparing the efficacy and safety of CellCept® with delayed introduction of sirolimus and discontinuation of cyclosporine, to those of standard immunosuppression comprising Cellcept and long-term continuation of cyclosporine in renal transplant recipients receiving an induction by Zenepax® and treated with corticosteroids for 8 months
Fast Facts:
| Protocol number: | ML18326 |
| Sponsor: | Roche SAS |
| Company division: | Pharmaceutical |
| Product name: | CellCept |
| Generic name: | mycophenolate mofetil |
| Phase of development: | IV |
| Therapeutic area, approved indication: | Kidney Transplantation |
| Date of report: | To be Published |
Clinical study summary:
This trial does not yet have clinical trial results posted on this website. All trial results will be posted within one year of approval or one year after trial completion, unless the release of information is restricted due to journal publication timing or pending regulatory filing. For further information on the timing of posting clinical trial results please consult the Roche policy for posting information on this website.
Click here for the protocol registry listing of this trial.
